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Summary.-Six phenols [2(3)-t-butyl-4-hydroxyanisole (BHA), 2-t-butylphenol,
4-methoxyphenol, 4-methylmercaptophenol, t-butylhydroquinone and 2,6-di-t-
butylphenol] previously shown to be inhibitors of benzo(a)pyrene-induced neoplasia,
were examined for their ability to induce in vivo changes in hepatic mono-oxygenase
and detoxication enzyme activities, and to act as mono-oxygenase inhibitors when
added in vitro. (1) Generally it was found that cytochrome P450 levels were depressed,
only 2,6-di-t-butylphenol caused a 2-fold induction (2) Mono-oxygenase activities
were significantly altered; BHA and 2,6-di-t-butylphenol caused microsomes to
show substantial increases in aniline hydroxylase and peroxidase activities. These
microsomes, along with 4-methoxyphenol microsomes, also showed a substantial
reduction in DNA binding of benzo(a)pyrene (BaP) metabolites relative to meta-
bolism. (3) Detoxication enzymes glutathione S-transferases and epoxide hydratase
were readily induced, the order of effectiveness being: BHA -2,6-di-t-butylphenol>
4-methoxyphenol >2-t-butylphenol - t-butylhydroquinone(4-methylmercaptophenol
failed to induce). (4) In vitro ability to inhibit BaP metabolism and DNA-binding
ability was: 2,6-di-t-butylphenol , BHA-2-t-butylphenol>t-butylhydroquinone>
4-methylmercaptophenol1>4-methoxyphenol. (5) Ability in vitro to discharge the
activated oxygen complex of cytochrome P450 was: 2,6-di-t-butylphenol-,2-t-butyl-
phenol > BHA > t-butlyhydroquinone >4-methylmercaptophenol >4-methoxyphenol.
The results are consistent with the theory that inhibition of neoplasia is related to
inducibility of detoxication enzymes, though alterations in cytochrome P450 could
play a significant role in some cases.
THE PHENOLIC ANTIOXIDANT 2(3)-t-
butyl-4-hydroxyanisole (BHA) is a widely
used food additive which has a number
of interesting and potentially important
pharmacological properties. When added
to commercial diets, iteffectively inhibited
neoplasia at several sites induced by a
variety ofcarcinogens (Wattenberg, I 972a,
b; 1973). BHA was also found to lower
the mutagenicity of BaP and other
promutagens both in vivo (Batzinger et al.,
1978) and in vitro (Rahimtula et al., 1977;
Calle et al., 1978; McKee & Tometsko,
1979). Dietary administration of BHA to
female mice has been shown to increase
several fold the specific activities of the
Phase II detoxication enzymes, gluta-
thione S-transferases and epoxide hydra-
tase, in the liver and other tissues (Benson
et al., 1978a, b; Cha et al., 1978). UDP-
glucuronyl transferase activity was also
enhanced (Cha & Bueding, 1979). BHA
feeding slightly lowers hepatic cytochrome
P450 levels, alters the metabolite profile
of BaP and shows a 5000 decrease in the
in vitro binding of BaP metabolites to
DNA (Speier & Wrattenberg, 1975; Lam
& Wattenberg, 1977; Lam et al., 1.980).
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Several pheinolic compounds (including
BHA) also inhibit the in vitro metabolism
of BaP in liver and other tissues of the
rat (Rahimtula et al., 1979). BHA also
acts as ani excellent peroxidase donor,
thereby serving to discharge the active
hydroxylating complex of cytochrome
P450 and inhibiting metabolism (Rahim-
tula et al., 1980). These data show that
BHA feeding can inhibit BaP-induced
carcinogenesis by several possible mechan-
isms: (a) increase in the levels of Phase
II detoxication enzymes, (b) alteration in
the type of cytochrome P450, leading to
decreased formation of electrophilic meta-
bolites, (c) competitive inhibition of car-
cinogen activation and discharge of the
active hydroxylating complex, (d) com-
bination of a, b, and/or c.
Recently, Wattenberg et al. (1980)
showed that a variety of phenols added
to the diet inhibited BaP-induced neo-
plasia of the forestomach of mice. 4-Meth-
oxyphenol and BHA were the most effec-
tive, and reduced the number of tumours/
mouse by about 7500, whilst other related
phenols were less effective. In this paper
we have examined the effect of feeding
the 6 phenols, BHA (mixed isomers),
t-butylhydroquinone, 4-methoxyphenol,
4-methylmercaptophenol 2-t-butylphenol
and 2,6-di-t-butylphenol on (a) liver
cytochrome P450 levels and monooxygen-
ase activities, and (b) liver Phase II
detoxication enzyme activities which
include glutathione-S-transferase(s), epox-
ide hydratase and UDP-glucuronyl trans-
ferase. We have also looked at the ability
of these phenols to serve as cytochrome
P450 peroxidase donors, as well as to
inhibit BaP metabolism and DNA bind-
ing, when added to normal microsomes
in vitro. Our aim was to discover: (i) which
structural feature(s) of the BHA molecule
are required for Phase II enzyme induc-
tion, and (ii) whether these changes (if
any) in Phase II enzymes were sufficient
to account for the in vivo inhibition of
BaP-induced neoplasia in mice observed by
WN'attenberg et al. (1980) or were additional
mechanisms also likely to be involved.
MIATERIALS ANDI) MIETHOD)S
2-t-Butylphenol: 4-methoxyphenol;
4-methylmercaptophenol: t-butylhydroqui-
none: 2.6-di-t-butylphenol; 1,2-dichloro-4-
nitrobenzene (DCNB) and 1-chloro-2,4-dini-
trobenzene (CDNB) were obtained from
Aldrich Chemical Co. CDNB and DCNB were
crystallized from aqueous ethanol before use.
NADPH, UDP glucuronic acid, glutathione
(GSH), BHA, aniline, aminopyrine, BaP, and
N,N,N',N' -tetramethyl -p-phenylenediamine
(TMPD) were purchased from Sigma Chemi-
cal Co. Cumene hydroperoxide (CHP) was
supplied by ICN Chemicals. BaP-4,5-oxide
,was a generous gift of the National Cancer
Institute Chemical Repository, Bethesda,
MD, U.S.A.
Female CD-i mice (Canadian Breeding
Labs, Montreal, PQ) 8 weeks old, were
lioused in metabolic cages (3 mice/cage) with
free access to 'water and food. The mice
were fed an AIN-76 semi-purified diet con-
taining 42 nmol of the test compound/kg of
diet. Control groups received just the AIN-76
diet. These diets wuere fed to the mice for
12 days. The mice w-ere killed by cervical
dislocation and the livers of each group were
combined (3/group). Microsomes were pre-
pared by differential centrifugation of liver
homogenates, as described by Remmer et al.
(1967). Isolated microsomes were washed
twice to minimize contamination of the
cytosolic fraction and frozen in suitable
aliquots at -80°C. They were used within
2 weeks of freezing. Protein was determined
by the Lowrv method (1951) and cytochrome
P450 by the method of Omura & Sato (1964).
BaP 3-hydroxylase wtas measured fluori-
metrically by the method of Nebert &
Gelboin (1968). All other enzymic assays -were
carried out by established procedures. Incuba-
tions were carried out in 0IM Tris HCI
(pH 7 5) at 37°C for 10 min and contained
per ml: 150 ,ug microsomal protein, 20 nmol
BaP in 5 ,ul DMSO and an NADPH-regenerat-
ing system. Different concentrations of the
various phenols were added in 6 pi of DMSO.
whilst the control contained 6 ,ul of DMSO
only. Total BaP metabolism w-as measured
by the assay procedure of Van Cantfort et al.
(1977) using [3H] BaP. Incubation condi-
tions were identical to the fluorimetric
assay. DNA binding of BaP metabolites was
carried out in 3 ml of 0IM Tris HCI (pH 7 5)
at 37°C for 20 min and contained 1 mg
microsomal protein. 2 mg calf thymus DNA,
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60 nmol [3H]BaP(72 ct/min/pmol) in 15 tul
DMSO. the various phenols in 18 ,ul DMSO
(or 18 pA DMSO for controls) and an NADPH-
regenerating system. Aniline hydroxylationi
was measured essentially by the method of
Fujita & Mannering (1973). Incubations were
carried out in 2 ml of 0-IM Tris HCl (pH 7 4)
at 37°C for 15 min. and contained 10 Hmol
aniline HCI, 3 mg microsomal protein and
an NADPH-regenerating system. Incubations
for aminopyrine N-demethylase wkere carried
out in 2 ml of 0-IM phosphate buffer (pH 7-5)
at 37°C for 10 min, and contained 6 Humol
aminopyrine, 1 mg microsomal protein and
an NADPH-regenerating system. Formalde-
hyde released was measured by the method
of Nash (1953). TMPD peroxidase was
measured spectrophotometrically, as des-
cribed by O'Brien & Rahimtula (1978). The
reaction was carried out in 3 ml cuvettes at
25°C and contained 300 jtmol phosphate
buffer (pH 7 5), 0-6 Htmol TMPD and 0-6
yunol cumene hydroperoxide (CHP). TMPD
oxidation was monitored at 610 nm (mME =
11-6). UDP glueuronyl transferase was
measured by the method of Bock & White
(1974). Incubations were carried out in
0OIM Tris HCI (pH 7.4) at 37°C for 2 min
and contained 5 ,umol MgC92. 0-0500
Triton X-100, 0-5 Humol o-naphthol, 0-3 ,uinol
UDP glucuronic acid and 1 mg micro-
somal protein. Glutathione S-transferase
with CDNB and DCNB was measured
exactly as described by Habig et al. (1974).
Epoxide hydratase was measured by the
method ofDansette et al. (1979). The reaction
was carried out in a lml cuvette and con-
tained 0-IM Tris HCI (pH 8.7) 20 nmol
BaP-4,5-oxide and 0(5 mg microsomal
protein.
RESULTS
The effects of dietary admninistration of
BHA and other phenols to female CD-i
mice for 12 days is shown in Tables I-IV.
Only BHA and 2,6-di-t-butylphenol
caused a marked increase in liver weight
relative to body weight, the other phenols
showing a significant change (Table I).
The enlargement of the liver on BHA
feeding has been reported prexviously by
Cha & Bueding (19.79). Generally, cyto-
chrome P450 levels were depressed 1 2
25%, and only 2,6-di-t-butylphenol
TABLE I. Effect of feeding BHA and
relatedl phenols on liverweight of mice
I)iet
Control
BHA
2,6-Di-t-b)utyl-
pl)enol
t-Buty1hydro-
quiinone
4-Methylinereapto-
plienol
4-Methoxyphenol
2-t-Bttylplenol
Wt/rnollse*
(g)
31 3 + 1 6
:1 7 + 1 8
:0 8+ 1 6
Liver
wt/
Liver wt* BodywNt
(g) (%)
2 25+0-15 7 2
3 05+0-16 9*6
2 85+0.15 93
298-18+ I 0-2 0 0:3+0 14 6-8
30 5+ 1 8 2- 2:3+0-14 7 :3
:3(05 +1 .9( 2 1 + 69 1: 6 53
:3 8+1) 2 -15+0 68 6 -
* lean of 9 mice/grou).
doubled cytochrome P450 levels (Table
II). Aminopyrine N-demethylase activity
generally reflected changes in cytochrome
P450 levels, though higher specific activi-
ties were observed with aniline hydroxy-
lase on BHA and other phenol feeding
(Table II). Thus BHA and 4-methyl-
mereaptophenol microsomes had a 50-
65% higher aniline hydroxylase activity
over control microsomes per mol of
cytochrome P450. As well as its mono-
oxygenase properties, cytochrome P450
can also serve as a peroxidase (Hrycay &
O'Brien, 1972). Dietary feeding of BHA
and 2,6-di-t-butylphenol increased TMPD-
CHP peroxidase activity - 60% and
225% respectively (Table II). The other
phenols produced less significant changes
in peroxidase activity. Table III shows
the effect of feeding these phenols on
BaP metabolism and DNA binding capa-
city. Both the fluorescent assay, which
detects only the phenolic metabolites,
and the radioactive assay, which detects
total metabolism, were performed. Rela-
tive to controls, BHA microsomes gave
14% less phenols but 300o less total
metabolism. Similarly, 2,6-di-t-butyl-
phenol microsomes yielded only 14%
more phenolic metabolites, while overall
metabolism was increased by 75%. The
other treated microsomes showed similar
but less substantial changes. More sig-
nificantly, 4-methoxyphenol and BHA
feeding reduced the ability of the micro-
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TABLE II.-Effect of feeding BHA and related phenols on mouse hepatic cytochrome
P450 levels and monoxygenase activities
Diet
Control
BHA
2,6-Di-t-butylphenol
t-Butylhydroquinone
4-Methylmercaptoplhenol
4-Methoxyphenol
2-t-Butylphenol
Cyt P450
nmol/mg
1 -04+ 0- 10
0-92+0-08
1-97+0-13
1 -07+0-09
0-83+0-09
0-79+0-08
0.95+0-10
Aniline Aminopyrine TMPD: CHP
hydroxylase N-demethylase peroxidase
(% of control) (0° of control) (0 ofcontrol)
100+8 100+ 7 100+4
132+ 10 78+7 156+6
222+ 17 170+ 18 226+ 13
109+9 81+7 92+8
130+15 98+7 90+6
106+9 83+8 102+7
117+8 95+6 92+8
Sp. act. (nmol/min/mg protein) using control microsomes are the following: Aniline hydroxylase,
1-23+0-10; Aminopyrine N-damethylase, 16-2+ 1 1; TMPD:CHP peroxidase, 100-9+3-7.
All assays were performed in duplicate, using microsomes prepared from 3 pooled livers. Standard deviation
was obtained using means from 3 pooled groups. Details of the individual assay conditions are described in
Materials and Methods.
TABLE III.-Effect offeeding BHA and related phenols on mouse hepatic BaP hydroxyla-
tion and DNA-binding capacity
Diet
Control
BHA
2,6-Di-t-butylphenol
t-Butylhydroquinone
4-Methylmercaptophenol
4-Methoxyphenol
2-t-Butylphenol
BaP Hydroxylase*-~~~~A
Fluorescence Radioactive
(0% ofcontrol) (0% ofcontrol)
100+ 7 100+10
86+6 71+8
114+8 175+ 14
103+8 88+8
96+6 79+6
86+6 90+8
129+ 10 118+ 10
Binding to DNAt
-GSH + 1mM GSH
(0 of control) (0% of control)
100+8 100+8
47+4 50+6
96+9 112+9
92+7 94+7
99+10 91+8
73+7 68+6
96+8 88+7
* Sp. act. of BaP hydroxylase (pmol/min/mg protein) using control microsomes are the following: 418+ 27
(fluorescence assay); 1456 + 150 (radioactive assay).
t Sp. binding (pmol/20 min/mg DNA) using control microsomes in the absence of GSH was 59 3 + 4-8.
All assays were performed in duplicate using microsomes from 3 pooled livers. Standard deviation was
obtained using means from 3 pooled groups. Details of the individual assay conditions are described in
Materials and Methods.
TABLE IV.-Effect offeeding BHA and relatedphenols on some mouse hepatic detoxication
enzymes
Diet
Control
BHA
2,6-Di-t-butylphenol
t-Butylhydroquinone
4-Methylmereaptophenol
4-Methoxyphenol
2-t-Butylphenol
UDPG Epoxide GSH-DCNB
transferase hydratase S-transferase
o-napththol BaP-4,5-oxide (supernatant)
100+12 100+ 10 100+ 9
193+ 18 654+ 49 770+ 54
194+ 21 782+ 59 584+ 49
68 + 9 128 +10 216 + 15
75+9 100+8 62+9_
87 + 9 223 + 15 339+ 45
103+6 159+ 10 245+ 19
Activity expressed relative to control as 100. Sp. act. (nmol/min/mg protein) using control microsomes
or cytosol are the following: UDPG transferase, 18-1 + 2-1; epoxide hydratase, 039 +004; GSH-DCNB
S-transferase, 46-9 + 4-1; GSH-CDNB S-transferase (supernatant), 1136 + 80; GSH-CDNB S-transferase
(microsomal), 37-6 + 2 9.
All assays were performed in duplicate, using microsomes or cytosol preparedfrom 3 pooledlivers. Standard
deviation was obtained using means from 3 pooled groups. Deails of the individual assay conditions are
as described in Materials and Methods.
GSH-CDNB
S-transferase
(supernatant)
100+7
717+ 85
500 + 37
225+ 16
100+ 11
252 + 27
208+ 18
GSH-CDNB
8-transferase
(microsomal
100+ 8
213+17
213 +18
108+ 11
125+10
150+ 13
121 + 13
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somes to catalyse the binding of BaP
metabolites to DNA, by 27% and 53%.
2,6-di-t-butylphenol feeding, which raises
BaP metabolism by 75%, does not induce
any additional DNA binding over con-
trols. Addition of 1mM GSH to the
incubation medium increased the DNA
binding in all cases, with BHA and
2,6-di-t-butylphenol microsomes showing
the largest increases (19% and 29%
respectively). Table IV shows the effect of
feeding these phenols on Phase II detoxi-
cation enzyme activities. UDP glucuronyl-
transferase activity, measured with
oa-naphthol as acceptor, is doubled on
BHA and 2,6-di-t-butylphenol feeding
and reduced by a third on t-butylhydro-
quinone feeding. The other phenols caused
less substantial changes. Epoxide hydra-
tase activity with BaP-4,5-oxide doubled
on 4-methoxyphenol feeding, andincreased
6-5-8-0-fold on BHA and 2,6-di-t-butyl-
phenol feeding. Cytosolic GSH S-trans-
ferases with DCNB and CDNB increased
2-fold on 2-t-butylphenol and t-butyl-
hydroquinone feeding, 3-fold on 4-meth-
oxyphenol feeding, 5-4-fold on 2,6-di-t-
butylphenol feeding and 7-5-fold on BHA
feeding. Microsomal GSH-CDNB S-trans-
ferase was also increased 50% on 4-meth-
oxyphenol feeding, and more than
doubled on BHA and 2,6-di-t-butylphenol
feeding. The other phenols were less
effective.
The effect of in vitro addition of these
phenols on BaP metabolism and DNA
150 300
BHA (PM)
0
100
50[
150
2-T-BUTYLPHENOL (PM;
300 0 150 300
14-METHOXYPHENOL (PM)
>
0 150 300 0 150 300 0 150 300
2,6-DI T-BUTYLPHENOL (PM) T-BUTYLHYDROQUINONE (GM) 4-METHYLMERCAPTOPHENOL (GM)
FIa. Effect of itn vitro addition of BHA and relate(l phenols oni the metabolism (0-O-0) and
DNA binding (0-0-0) of BaP by mouse liver microsomes. BaP hydroxylation was measured
fluorimetrically as described in the text. Each ml of the incubation mixture contained 0-iM Tris
HCl (pH 7.5) 0-15 mg microsomal protein from control mice, 20 nmol BaP and an NADPH-
regenerating system. For DNA binding, each ml of incubation mix contained 0-IM Tris HCl
(pH 7.5) 0-33 mg microsomal protein from control mice, 0 67 mg calf thymus DNA, 20 nmol [3H]-
BaP and an NADPH-regenerating system. The various phenols were added in 6 ,u of DMSO per
ml of incubation medium, whilst the control contained 6 ,u of DMSO only. Results are expressed
relative to "NO ADDITION" as 100O/.
100
50
I-1
I-e
(-)
>
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-120 SEC FNO ADDITION
A 4-METHY OPHEL
0.002
/ [+~~~L-METHOXYPHENOL
m ~~T-BUTYLHYDROQUINONE
6-DI-T-BUTYLPHENOL OR BHA
- -- ~~~~~T LPEOL
t 50 i41 CHP
Fic'e. 2. Effect of in vitro addition of BHA and(i relate(1 pheiiols oni the foirnationi of the 440Ilim
complex. 6 mg of microsomes was suispelde(l in 6 ml of 0-I u PBS (pH 7 5). The suspension was
equally (listributed1 between two cuvettes refrigerated at 10°C to obtain a baseline of equal absorb-
ance 5 ,ul of a 30nii solutioin of CHP wN-as added to the sample cinvette aii(1 the absorbance ehange'
at 440 nm waas recor(le(l. The various phenols were addle(l in 2 ,u1 of DMSO/6 ml of mierosomal
suspension, to a final con(entration of 17 Lu.
binding catalysed by control mouse liveer
microsomes is shown in Fig. 1. Generally,
DNA binding was more significantly
inhibited than metabolism (3-hydroxy
BaP formation). Fifty per cent inhibition
of BaP-DNA adduct formation was obser-
ved with 251tM 2,6-di-t-butylphenol, 75jari
2-t-butylphenol, BHA and t-butylhydro-
quinone, and 225/tM 4-methylmercapto-
phenol. 4-Methoxyphenol (up to 300 tLM)
failed to significantly decrease BaP meta-
bolism or DNA binding.
Addition of CHP to liver microsomes
leads to the formation of a higher oxida-
tion state of cytochrome P450, with a
peak at 440 nm (Rahimtula et al., 1974)
and also to the oxidation of a variety of
substrates such as BaP, aniline, amino-
pyrine, p-nitroanisole, etc. (Rahimtula &
O'Brien, 1974, 1975). Fig. 2 shows the
relative effectiveness with which these
phenols, at a concentration of 17 ,iATr, are
able to prevent the formation of the
440nm complex. The order of effective-
ness was found to be 2-t-butylphenol>
BHA 2,6 - di - t - butylphenol > t - butyl-
hvdroquinone > 4-methoxyphenol > 4-
methylmercaptophenol. About the same
effectiveness was found when the dis-
charge of the preformed 440nm complex
was measured on addition ofthese phenols
(data not shown).
D)ISCUSSION
In the present investigation, 6 phenols
were studied for their in vivo effects on
hepatic monooxygenase and Phase II
enzyme activities, and their ability in
vitro to interact with and inhibit BaP
metabolism, DNA binding, etc. Generally,
all phenols slightly reduced hepatic cyto-
chrome P450 and monooxygenase levels,
with the exception of 2,6-di-t-butyl-
phenol, which about doubled both cyto-
chrome P450 and mixed-function oxidase
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levels (Table II). This suggests that both
ortho positions of the phenolic OH must
be occupied by t-butyl in order to induce
cytochrome P450, because 2-t-butvl-
phenol which has one ortho position
vacant is not an inducer (Table II).
Cytochrome P450 was decreased by other
phenols, but the Phase II detoxication
enzyme levels were induced (Table IV).
Generally, GSH transferase was most
easily induced, followed by epoxide hydra-
tase, and a good induction of GSH
transferase was accompanied by a corre-
spondingly good induction of epoxide
hydratase, suggesting that the regulation
of these enzymes is related. In contrast,
UDP-glucuronyl transferase activity was
only doubled by BHA and 2,6-di-t-
butylphenol, and remained essentially
tunchanged or even diminished by the
other phenols. The elevation of GSH
transferase activity 3-fold by 4-meth-
oxyphenol, and its lack of elevation
by 4-methylmercaptophenol suggests that
the methoxy group para to the phenolic
OH is essential for induction. The import-
ance oft-butyl groups is implicated by the
fact that 2-t-butylphenol and 2,6-di-t-
butylphenol feeding elevate hepatic GSH-
transferase activity 2-fold and 5-fold
respectively. These observations are sub-
stantiated by the finding that BRA,
which has both methoxy and t-butyl
groups, induces much greater GSH-trans-
ferase activity (Table IV; Benson et al.,
1 978a).
Wattenberg et al. (1980) have already
shown that feeding of 4-methoxyphenol
and 3-t-butyl-4-hydroxyanisole (the minor
isomer of BHA) to mice resulted in a 75%o
drop in BaP induced tumours of the fore-
stomach while the feeding of equimolar
amounts of2-t-butylphenol, 2,6-di-t-butyl-
phenol, t-butyl-hydroquinone and 2-t-
butyl-4-hydroxyanisole (the major isomer
of BHA) resulted in a 40-50%0 drop in the
incidence of neoplasia. According to
Oesch (1972) any factors decreasing the
steady-state levels of epoxides would
reduce the carcinogenic effects of p)oly-
cyclic aromatic hydrocarbons. A redutction
in steady-state levels of BaP epoxides can
be achieved, by" either slower formation
or faster removal. Epoxide hydratase and
glutathione 8-transferases are enzymes
that interact with epoxides, converting
them to dihydrodiols and glutathione con-
jugates respectively. While epoxide hydra-
tase is generally considered a detoxication
enzyme (Oesch, 1972), its protective role
in BaP-induced neoplasia is questionable,
because it is the enzyme responsible for
converting BaP-7,8-epoxide into BaP-7,8-
dihydrodiol, the precursor of the ultimate
carcinogen, BaP-7,8-diol-9,10-epoxide
(Kahl et al., 1978; Guenthner & Oesch,
1981). There appears to be a modest
correlation between GSH 8-transferase
inducibility (Table IV) and protection
against BaP-induced neoplasia (Watten-
berg et al., 1980). BHA and 4-methoxy-
phenol, which are good inducers, offer
superior protection whilst 2-t-butylphenol
and t-butylhydroquinone, which are fair
inducers, offer moderate protection. Very
recently Sparnins & Wattenberg (1981)
have shown that the ability of the 2
isomers of BHA to inhibit BaP-induced
neoplasia of the forestomach correlates
positively with their ability to induce
GSH S-transferase. Wre also find that
BHA and 2,6-di-t-butylphenol feeding
causes a 2-fold induction of microsomal
GSH S-transferase (Table IV). Previous
reports have shown that several xeno-
biotics can increase the cytosolic but not
the microsomal GSH S-transferase activity
(Friedberg et al., 1979; Morgenstern et al.,
1980). Increases in GSH S-transferase
activity is not due to activation by anti-
oxidants, since addition ofBHA to control
supernatant or microsomes does not raise
GSH S-transferase activity. The proximity
of the microsomal GSH 8-transferase to
the site of generation of the active BaP
metabolites makes it an attractive candi-
date for detoxication. Addition of ImAi
GSH to the incubation medium failed to
lower the binding of BaP metabolites to
added DNA; indeed, a small stimulation
was observed (Table III). Curiously, BHA
and 2,6-di-t-butylphenol microsomes,
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which showed maximum induction of
microsomal GSH S-transferase, also
showed the greatest increase in binding of
BaP to DNA in the presence of GSH8
(Table III; 19% and 29% resp.). These
data suggest that microsomal transferase
is not significant in the detoxication of
reactive BaP metabolites.
Other factors, notably a change in the
nature and levels of cytochrome P450,
may also have a significant impact on
BaP-induced neoplasia. Microsomes from
BHA-fed mice showed a 14% decrease in
3-OH-BaP formation, a 30%o decrease in
total BaP-metabolite formation and a
53% decrease in DNA-binding (Table III).
This shows that BaP metabolism and
activation are substantially altered by
BHA feeding. Lam et al. (1980) also noted
a 3000 decrease in total BaP-metabolite
formation by BHA-treated microsomes.
HPLC separation of the various meta-
bolites revealed that the relative amounts
of each metabolite had also changed. In
female NMRI mice we have found that
the relative amount of BaP-4,5-diol is
increased 5-fold and that of 9-OH-BaP
decreased by 80-90% (manuscript in
preparation). Since 9-OH-BaP-4,5-oxide
is one of the components binding to DNA
(Guenthner et al., 1979) a decrease in
total DNA binding may be due primarily
to lower levels of 9-OH-BaP. A lowering
in the DNA-binding capacity on feeding
BHA is consistent with its role as inhibitor
of BaP-induced neoplasia. Similarly,
4-methoxyphenol, another excellent inhib-
itor of BaP-induced neoplasia, also
decreased the ability of microsomes to
catalyse binding of BaP metabolites to
DNA by 27%o (Table III). Perhaps the
reason that 2,6-di-t-butylphenol, a good
inducer of GSR 8-transferase (Table IV)
is a relatively moderate protector may be
because it is also an inducer of cytochrome
P450 (Table II). An induction of cyto-
chrome P450 would lead to an increased
formation of BaP metabolites, which
might partially offset the advantage
gained by induction ofGSH 5-transferases.
These data suggest that an in vivo change
in the nature of hepatic cytochrome P450
can affect BaP metabolism and DNA
binding, and thereby inhibit BaP-induced
carcinogenesis.
WlTe have also looked for a possible
correlation between the ability of these
phenols to interact directly with cyto-
chrome P450 and inhbit BaP metabolism,
DNA binding, etc. on the one hand and
their ability to protect against BaP-
induced neoplasia on the other. Several
antioxidants, including BHA and BHT,
bind to liver microsomal cytochrome
P450, producing a difference spectrum
(Yang et al., 1975) and inhibit the meta-
bolism of BaP in vitro (Rahimtula et al.,
1979). Assuming a normal daily food
consumption of 2 g, each mouse took
84 jumol of phenol per day. For an
even distribution in the body and no
significant accumulation, this would
amount to a concentration of - 2'8 mivi
in a 30g mouse. The results in Fig. 1,
showing that BaP metabolism and DNA
binding are substantially inhibited by
much lower levels of phenols, suggests
that consumption of these phenols might
slow down BaP metabolism. However,
there appears to be little correlation
between the ability of these phenols to
inhibit BaP metabolism and DNA bind-
ing in vitro (Fig. ]) and their ability to
prevent BaP-induced neoplasia. The fact
that 4-methoxyphenol, an excellent in
vivo protector, is a very poor in vitro
inhibitor of BaP metabolism and DNA
binding, suggests that such a direct
interaction between phenol and cyto-
chrome P450 might be oflittle importance
in inhibiting neoplasia. The other phenols
like BHA, 2-t-butylphenol, 2,6-di-t-butyl-
phenol and t-butylhydroquinone were
good inhibitors of BaP metabolism and
DNA binding and it is possible that such
a direct interaction plays a role in inhibit-
ing neoplasia by these phenols. Their
degree of in vitro inhibition of BaP meta-
bolism and DNA binding correlates well
with their ability to act as electron donors
in discharging the active hydroxylating
species of cvtochrome P450, thereby
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inhibiting substrate metabolism (Fig. 2).
We have previously shown that cyto-
chrome P450 can act as a peroxidase, and
that organic hydroperoxides like CHP can
effectively replace NADPH, the flavo-
protein NADPH-cytochrome P450 reduc-
tase and molecular oxygen in hydroxylat-
ing drugs and carcinogens (Rahimtula &
O'Brien, 1974; 1975). Antioxidants like
BHA, BHT and TMPD inhibit the
NADPH-dependent and CHP-dependent
monooxygenationofBaPtosimilarextents,
suggesting similar modes of inhibition
(Rahimtula et al., 1974). In the presence
of CHP, liver microsomes also give rise to
a spectral complex with a peak at 440 nm
(Rahimtula et al., 1974). Similar spectral
complexes are seen on addition of per-
oxides to haemoproteins, and a discharge
of the complex by the addition of various
compounds indicates that they are per-
oxidase donors (George & Irvine, 1953;
Yamasaki & Yokota, 1973). The ability
of these phenols to prevent the formation
of the 440nm complex is shown in Fig. 2.
Here it was found that 2-t-butylphenol,
2,6-di-t-butylphenol and BHA were better
electron donors, whilst 4-methoxyphenol
and 4-methylmercaptophenol were poor
electron donors. The same order of effici-
ency was observed by these phenols in
their ability to discharge the preformed
440nm complex (data not shown) which
suggests that the various phenols can
bind to and discharge the higher oxidation
states of cytochrome P450, thereby pre-
venting substrate hydroxylation. In the
case of efficient electron donors, such a
direct interaction might play a role in
inhibiting neoplasia.
In conclusion, it appears that the
ability of the various phenols to inhibit
BaP-induced neoplasia correlates best
with their ability to induce the detoxica-
tion enzymes GSH S-transferases, though
in vivo alterations in the nature and levels
of cytochrome P450 could be a contri-
butory factor in some cases. Direct
interaction of these phenols with cyto-
chrome P450 would be expected to play a
minor role in inhibiting neoplasia.
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